Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Delayed London Stock Exchange  -  11:35 2022-12-02 am EST
11178.00 GBX   -0.20%
12/02Vaxxinity's Phase 3 COVID-19 Vaccine Trial Meets Endpoints
MT
12/02Innate pharma to present adenosine franchise, iph5201 and iph5301 at esmo io 2022
AQ
12/02ASTRAZENECA : Deutsche Bank reaffirms its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Credit Suisse Downgrades AstraZeneca to Neutral From Outperform, Citing Valuation After Year-to-Date Stock Climb; Price Target Kept at GBP110

09/15/2022 | 08:41am EST


ę MT Newswires 2022
All news about ASTRAZENECA PLC
12/02Vaxxinity's Phase 3 COVID-19 Vaccine Trial Meets Endpoints
MT
12/02Innate pharma to present adenosine franchise, iph5201 and iph5301 at esmo io 2022
AQ
12/02ASTRAZENECA : Deutsche Bank reaffirms its Buy rating
MD
12/01Astrazeneca : Transparency Directive - Form 6-K
PU
12/01AstraZeneca showcases strength of hematology portfolio and pipeline across multiple har..
AQ
12/01University Of Oslo : Joining forces to help life science start-ups
AQ
11/30FDA pulls U.S. authorization for Eli Lilly's COVID drug bebtelovimab
RE
11/30Global markets live: Apple, Tesla, Boeing, HP, Intuit...
MS
11/30AstraZeneca showcases strength of haematology portfolio and pipeline across multiple h..
AQ
11/30Astrazeneca : showcases strength of haematology portfolio and pipeline across multiple har..
PU
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2022 44 442 M - -
Net income 2022 4 087 M - -
Net Debt 2022 23 636 M - -
P/E ratio 2022 49,0x
Yield 2022 2,16%
Capitalization 212 B 212 B -
EV / Sales 2022 5,31x
EV / Sales 2023 4,97x
Nbr of Employees 83 100
Free-Float 96,5%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 136,92 $
Average target price 144,75 $
Spread / Average Target 5,72%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC28.81%212 164
JOHNSON & JOHNSON4.57%467 679
ELI LILLY AND COMPANY34.07%356 089
ABBVIE INC.20.87%289 331
NOVO NORDISK A/S22.04%285 887
PFIZER, INC.-13.50%285 774